Download references
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours
-
* Corresponding author: Sandra E Dunn sedunn@interchange.ubc.ca
Breast Cancer Research 2005, 7:R796-R807 doi:10.1186/bcr1294
Please see related commentary by Crowder and Ellis at: http://breast-cancer-research.com/content/7/5/212